Table 2 |
||||||
|
The prevalence of five or more (DP ≥ 5) dispensed drugs with and without ATC G031, J012 and N053. |
||||||
|
All individuals DP ≥ 5 |
Females DP ≥ 5 |
|||||
|
|
|
|||||
|
All drugs |
ATC G03 excluded |
ATC J01 excluded |
ATC N05 excluded |
All drugs |
ATC G03 excluded |
|
|
Age |
n = 2,227,152 |
2,131,961 |
1,997,440 |
2,111,966 |
1,356,934 |
1,262,497 |
|
|
||||||
|
0–9 |
6.6 |
6.6 |
3.6 |
6.5 |
5.7 |
5.7 |
|
10–19 |
6.2 |
5.2 |
4.3 |
5.9 |
8.3 |
6.4 |
|
20–29 |
9.9 |
8.3 |
7.5 |
9.1 |
15.2 |
11.8 |
|
30–39 |
13.9 |
12.5 |
11.2 |
12.8 |
19.7 |
16.7 |
|
40–49 |
18.4 |
17.4 |
15.9 |
16.8 |
23.8 |
21.8 |
|
50–59 |
30.2 |
28.9 |
27.4 |
28.3 |
36.3 |
33.5 |
|
60–69 |
42.3 |
41.1 |
39.4 |
40.4 |
46.8 |
44.4 |
|
70–79 |
62.4 |
61.6 |
60.0 |
60.2 |
65.5 |
64.1 |
|
80–89 |
75.1 |
74.7 |
73.2 |
72.7 |
77.3 |
76.7 |
|
90- |
77.7 |
77.4 |
75.9 |
74.7 |
79.4 |
79.0 |
|
|
||||||
|
Total |
24.4 |
23.4 |
21.9 |
23.2 |
29.6 |
27.5 |
|
|
||||||
|
The prevalence (%) of DP ≥ 5 for all individuals and for females, with and without ATC G03, J01, and N05 in Sweden in 2006. 1 Sex hormones and modulators of the genital system 2 Antibacterials for systemic use 3 Psycholeptics |
||||||
|
Hovstadius et al. BMC Clinical Pharmacology 2009 9:11 doi:10.1186/1472-6904-9-11 |
||||||
